In observance of the upcoming holidays, please note our revised hours. The Customer Support Center will be open 5 a.m.–2 p.m. PST on Friday, November 25, and will be closed Thanksgiving Day, Christmas Eve, Christmas Day, December 26, New Year’s Eve, New Year’s Day and January 2.

×

EMA®

$217*

*Price is per appliance and does not include shipping or applicable taxes.

Please note pricing is only available to dental professionals.

The EMA® appliance is designed to promote a deeper, more restful sleep by preventing snoring and relieving the symptoms of obstructive sleep apnea.

  • Appliance uses nine different lengths of elastic straps to gradually and incrementally advance the mandible
  • EMA patented design allows freedom of lateral mandibular movement
  • Patients can easily change the elastic straps

For a Better Night’s Sleep

The EMA (Elastic Mandibular Advancement) oral appliance is a customized removable appliance created for the noninvasive treatment of snoring and obstructive sleep apnea (OSA). The appliance is designed to both advance the mandible and open the bite to allow for less restricted airflow during sleep.

EMA devices help promote a deeper, more restful sleep by preventing snoring and relieving the symptoms of OSA. The EMA does not interfere with breathing through the mouth, even in cases of congested nasal passages. It has many options for advancement with nine strap lengths (13 mm–21 mm) and four different elastic tension options, indicated by color. The shorter the strap, the farther the mandible is advanced. The 36 different straps allow for the most effective repositioning of the jaw with maximum comfort. Due to the varying elastic bands, non-restricted lateral/protrusive movement is possible while wearing the device.

EMA is a registered trademark of Frantz Design Inc.

Validations

Patient Satisfaction

Oral appliance therapy (OAT) is very effective in treating patients with sleep-disordered breathing, with a compliance rate shown to be as high as 90% over a 2.5-year period.1

OAT is associated with greater patient satisfaction than nasal continuous positive airway pressure (CPAP) therapy.2

In a randomized crossover trial comparing OAT to CPAP in patients with obstructive sleep apnea, about 81% preferred OAT.3

Improved Health

Among patients with obstructive sleep apnea, both continuous positive airway pressure (CPAP) and mandibular advancement devices (MADs) were associated with reductions in blood pressure. Network meta-analysis did not identify a statistically significant difference between the blood pressure outcomes associated with these therapies.4

A mandibular advancement device for obstructive sleep apnea reduces nocturnal blood pressure in women.5

Treating Patients with the EMA

Left: Without the EMA, the patient’s airway is obstructed by soft tissues.

Right: The EMA allows for air to flow freely through the patient’s airway.

“For years I had accepted chronic fatigue as a natural progression of aging, not realizing that the lack of restful sleep was the real problem. I still remember vividly the first morning after I wore my EMA. It was the best night’s sleep I’d had in years!”

– Bryan R. (Patient)

Specifications

Indications

The EMA is indicated for patients with either a full or partial set of natural teeth. The patient’s remaining teeth should have sufficient height of contour for the device to gain retention at the gingival third, and the edentulous ridge must be fully captured in the impression.


Material Composition

Proprietary thermoplastic polymer and elastic straps


In-Lab Working Times

5 days


Available Colors

Clear


Pricing

  • EMA sleep apnea device: $217* per appliance
  • EMA sleep apnea device (Glidewell Clinical Twinpak™): $409* for 2 appliances

*Digital file storage is available for this product. For more information on our Scan & Save services, call us at 800-407-3326.

Pricing is subject to change and does not include shipping or applicable taxes.

Download price list


Policies & Warranty

NO-FAULT REMAKE POLICY: Glidewell is pleased to process all remakes or adjustments at no additional charge if requested within the warranty period and accompanied by the return of the original appliance.

LIMITED WARRANTY/LIMITATION OF LIABILITY. Glidewell (“the lab”) warrants that all dental devices (a “device”) are made according to your specification and approval in the belief that the device will be useful and MAKES NO OTHER WARRANTIES INCLUDING, BUT NOT LIMITED TO, ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Subject to the return of a device that is placed and then fails, the lab will repair or replace the device without charge for the cost of materials and workmanship or refund the original price paid, at the lab’s option, for up to 2 years for the EMA appliance.

Resources

Procedures

Loading results...

    No data

      Additional Resources

      Literature

      Loading results...

        No data

          Media

          Loading results...

              No data

                References

                1. ^ Yoshida K. Effects of a mandibular advancement device for the treatment of sleep apnea syndrome and snoring on respiratory function and sleep quality. Cranio. 2000 Apr;18(2):98-105.
                2. ^ Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral appliance vs. nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest. 1996 May;109(5):1269-75.
                3. ^ Tan YK, L’Estrange PR, Luo YM, Smith C, Grant HR, Simonds AK, Spiro SG, Battagel JM. Mandibular advancement splints and continuous positive airway pressure in patients with obstructive sleep apnoea: a randomized cross-over trial. Eur J Orthod. 2002 Jun;24(3):239-49.
                4. ^ Bratton DJ, Gaisl T, Wons AM, Kohler M. CPAP vs. mandibular advancement devices and blood pressure in patients with obstructive sleep apnea: a systematic review and meta-analysis. JAMA. 2015 Dec 1;314(21):2280-93.
                5. ^ Rietz H, Franklin KA, Carlberg B, Sahlin C, Marklund M. Nocturnal blood pressure is reduced by a mandibular advancement device for sleep apnea in women: findings from secondary analyses of a randomized trial. J Am Heart Assoc. 2018 Jun 21;7(13).